Targeting MAFB potentiates immune checkpoint inhibitor efficacy by reprogramming tumor-associated macrophages to an M1-like phenotype in colorectal cancer. - Choi SP; Yang J; Park IB; Kang SJ; Park SW; Lee CH; Lee HJ; Bae J; Choi CY; Shin J; Kim JI; Jin HY; et al. (Translational research : the journal of laboratory and clinical medicine, 2026)